SCHEMBL10112657

SCHEMBL10112657

NC(=O)C(CNCC1CC1)c1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
AKT1 P31749 2/20 0.45
AKT2 P31751 2/20 0.45
AKT3 Q9Y243 2/20 0.45
FFAR2 O15552 1/20 0.43
CNR1 P21554 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
F10 P00742 1/20 0.40
PRSS1 P07477 1/20 0.40
MAPT P10636 1/20 0.40
CNR2 P34972 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CACNA1G O43497 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2738495 1.00 NPC1 (0.46) NPC1RAB9AAKT1AKT2AKT3
SCHEMBL2738449 1.00 NPC1 (0.46) NPC1RAB9AAKT1AKT2AKT3
SCHEMBL191373 0.87 AKT1 (0.48) NPC1RAB9AAKT1AKT2AKT3
SCHEMBL191372 0.87 AKT1 (0.48) NPC1RAB9AAKT1AKT2AKT3
SCHEMBL2739192 0.85 HDAC3 (0.40) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL16131663 0.85 AKT1 (0.47) NPC1RAB9AAKT1AKT2AKT3
SCHEMBL684251 0.85 AKT1 (0.47) NPC1RAB9AAKT1AKT2AKT3
SCHEMBL684491 0.85 AKT1 (0.47) NPC1RAB9AAKT1AKT2AKT3
Hydrochloric Acid SCHEMBL193039 0.85 AKT1 (0.47) NPC1RAB9AAKT1AKT2AKT3
Hydrochloric Acid SCHEMBL193038 0.85 AKT1 (0.47) NPC1RAB9AAKT1AKT2AKT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012135749-A2 BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS GENENTECH, INC. (US) 2012-10-04 WO disclosed
WO-2012088254-A1 AUTOPHAGY INDUCER AND INHIBITOR COMBINATION THERAPY FOR THE TREATMENT OF NEOPLASMS GENENTECH, INC. (US) 2012-06-28 WO disclosed
WO-2011130654-A1 FOX03A AS PREDICTIVE BIOMARKER FOR PI3K/AKT KINASE PATHWAY INHIBITOR EFFICACY GENENTECH, INC. (US) 2011-10-20 WO disclosed